Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Prima BioMed Ltd (IMMP)

Context Therapeutics Inc. and Prima BioMed Ltd are both Biotechnology companies. Context Therapeutics Inc. and Prima BioMed Ltd are of similar size ($23.7M and $22.1M). Across the 9 metrics below, Prima BioMed Ltd leads on 5 and Context Therapeutics Inc. on 4.

Valuation

Metric CNTX IMMP Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.60 0.05 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (200.00%) (40.42%) (33.15%)
Free cash flow yield (148.95%) (1,275.20%) (25.50%)

Profitability

Metric CNTX IMMP Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) 0.00% (56.36%)
Return on assets (68.96%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX IMMP Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 17.39% (33.84%) 30.26%
Revenue growth, 5-year CAGR — 40.79% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX IMMP Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 5.81 2.97 4.72
Net debt to EBITDA 1.66 0.92 0.96

Dividend

Metric CNTX IMMP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTX IMMP Biotechnology median
Market cap 22.09m 23.66m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack